Hyaluronic acid as a treatment for ankle osteoarthritis

Description: Viscosupplementation refers to the concept of synovial fluid replacement with intra-articular injections of hyaluronic acid (HA) for the relief of pain associated with osteoarthritis (OA). Intra-articular viscosupplementation was approved by the Food and Drug Administration (FDA) in 1997. It is currently indicated only for the treatment of pain associated with knee OA. However, OA can occur in several of the weight-bearing joints of the foot and ankle. Ankle OA produces chronic disability that directly impacts the quality of life. There is only limited published literature relating to the use of HA in the ankle. This paper will review the authors’ experience, indications, clinical outcomes, and complications of viscosupplementation therapy in patients with ankle OA.
Hyaluronic acid as a treatment for ankle osteoarthritis Shu-Fen Sun, Yi-Jiun Chou, Chien-Wei Hsu, and Wen-Ling Chen Curr Rev Musculoskelet Med. 2009 June; 2(2): 78–82. full text